Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 15/20 | 0.40 |
| ▸ | AGTR1 | P30556 | 4/20 | 0.38 |
| ▸ | PPARG | P37231 | 1/20 | 0.36 |
| ▸ | CTRB1 | P17538 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL652577 | 0.88 | MME (0.39) | MMEPPARG | |
| SCHEMBL1074155 | 0.88 | MME (0.39) | MMEPPARG | |
| SCHEMBL652532 | 0.85 | MME (0.40) | MMEAGTR1CTRB1 | |
| SCHEMBL653074 | 0.85 | PPARG (0.49) | MMEAGTR1PPARG | |
| SCHEMBL1928982 | 0.85 | PPARG (0.49) | MMEAGTR1PPARG | |
| SCHEMBL3771299 | 0.84 | PPARG (0.45) | AGTR1PPARG | |
| SCHEMBL651961 | 0.79 | AGTR2 (0.42) | MMEAGTR1 | |
| SCHEMBL15253877 | 0.79 | MME (0.49) | MMECTRB1 | |
| SCHEMBL654625 | 0.78 | MMEL1 (0.41) | MME | |
| SCHEMBL654626 | 0.78 | MMEL1 (0.41) | MME |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 142 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260028305-A1 | PROCESS FOR CONTINUOUS CATALYTIC HYDROGENATION OF MDA | EVONIK OPERATIONS GMBH (DE) | 2026-01-29 | — | — | US | claimed |
| US-20260028306-A1 | PROCESS FOR PRODUCING METHYLENEBIS(CYCLOHEXYLAMINE) | EVONIK OPERATIONS GMBH (DE) | 2026-01-29 | — | — | US | claimed |
| US-20260028304-A1 | PROCESS FOR CONTINUOUS CATALYTIC HYDROGENATION OF MDA | EVONIK OPERATIONS GMBH (DE) | 2026-01-29 | — | — | US | claimed |
| US-20260027536-A1 | PROCESS FOR CONTINUOUS CATALYTIC HYDROGENATION OF MDA | EVONIK OPERATIONS GMBH (DE) | 2026-01-29 | — | — | US | claimed |
| US-20260027535-A1 | PROCESS FOR CONTINUOUS CATALYTIC HYDROGENATION OF MDA | EVONIK OPERATIONS GMBH (DE) | 2026-01-29 | — | — | US | claimed |
| EP-4631929-A1 | METHOD FOR PRODUCING DIAMINE CONTAINING CYCLOHEXANE RING | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2025-10-15 | — | — | EP | claimed |
| WO-2024122528-A1 | METHOD FOR PRODUCING DIAMINE CONTAINING CYCLOHEXANE RING | 三菱瓦斯化学株式会社 | 2024-06-13 | — | — | WO | claimed |
| US-10577512-B2 | Compatibilizer for universal colorant in solventborne alkyd paints | EVONIK OPERATIONS GMBH (DE) | 2020-03-03 | — | — | US | claimed |
| EP-3305840-B1 | COMPATIBILIZER FOR UNIVERSAL COLORANT IN SOLVENTBORNE ALKYD PAINTS | EVONIK DEGUSSA GMBH (DE) | 2019-11-06 | — | — | EP | claimed |
| EP-3305840-A1 | COMPATIBILIZER FOR UNIVERSAL COLORANT IN SOLVENTBORNE ALKYD PAINTS | Evonik Degussa GmbH (DE) | 2018-04-11 | — | — | EP | claimed |
| US-20180094146-A1 | COMPATIBILIZER FOR UNIVERSAL COLORANT IN SOLVENTBORNE ALKYD PAINTS | EVONIK DEGUSSA GMBH (DE) | 2018-04-05 | — | — | US | claimed |
| EP-3181611-A1 | AN ALICYCLIC DI-AMMONIUM DI-CARBOXYLATE SALT | Nexam Chemical AB (SE) | 2017-06-21 | — | — | EP | claimed |
| WO-2026099001-A1 | ADDITIVE COMPOSITION FOR POWDER COATINGS | EVONIK OPERATIONS GMBH (DE) | 2026-05-15 | — | — | WO | disclosed |
| US-20260028307-A1 | Process for the hydrogenation of MDA | EVONIK OPERATIONS GMBH (DE) | 2026-01-29 | — | — | US | disclosed |
| US-20260027536-A1 | PROCESS FOR CONTINUOUS CATALYTIC HYDROGENATION OF MDA | EVONIK OPERATIONS GMBH (DE) | 2026-01-29 | — | — | US | disclosed |
| US-20260027535-A1 | PROCESS FOR CONTINUOUS CATALYTIC HYDROGENATION OF MDA | EVONIK OPERATIONS GMBH (DE) | 2026-01-29 | — | — | US | disclosed |
| US-4841090-A | OIL AND WATER RESISTANCE | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1989-06-20 | — | — | US | disclosed |
| EP-0255990-A2 | Polytriazine compounds containing recurring piperidylamidinotriazine structural units and their use as stabilizers for organic materials | CIBA-GEIGY AG (CH) | 1988-02-17 | — | — | EP | disclosed |
| EP-0102690-B1 | TREATMENT OF FIBROUS SUBSTRATES, SUCH AS CARPET WITH FLUOROCHEMICAL | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1987-04-08 | — | — | EP | disclosed |
| EP-0102690-A1 | Treatment of fibrous substrates, such as carpet with fluorochemical | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1984-03-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260027535-A1 | PROCESS FOR CONTINUOUS CATALYTIC HYDROGENATION OF MDA | MDH1, MDH2, GPX1 | MME 2888/4885AGTR1 2631/4885PPARG 4324/4885 |
| US-20260028305-A1 | PROCESS FOR CONTINUOUS CATALYTIC HYDROGENATION OF MDA | MPO, MDH1, MDH2 | MME 3732/4885AGTR1 2715/4885PPARG 3562/4885 |
| US-20260028307-A1 | Process for the hydrogenation of MDA | MPO, MRM1, DNMT1 | MME 2637/4885AGTR1 1632/4885PPARG 3234/4885 |
| US-20260027536-A1 | PROCESS FOR CONTINUOUS CATALYTIC HYDROGENATION OF MDA | MPO, MDH1, MDH2 | MME 3376/4885AGTR1 2618/4885PPARG 4035/4885 |
| US-20260028304-A1 | PROCESS FOR CONTINUOUS CATALYTIC HYDROGENATION OF MDA | MPO, CAT, MDH1 | MME 3184/4885AGTR1 1655/4885PPARG 3545/4885 |
| US-20260028306-A1 | PROCESS FOR PRODUCING METHYLENEBIS(CYCLOHEXYLAMINE) | MVD, PNMT, HNMT | MME 308/4885AGTR1 2611/4885PPARG 3814/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.